Le Lézard
Classified in: Health
Subjects: PDT, FVT

InBody to Offer Solutions in Body Composition Analysis at American Diabetes Association 78th Scientific Sessions


CERRITOS, Calif., June 18, 2018 /PRNewswire-PRWeb/ -- InBody will offer body composition solutions to American Diabetes Association (ADA) 78th Scientific Sessions attendees, June 22 to June 25 in Orlando, FL. The medical device manufacturer will also offer complimentary, research-grade body composition analyses on the InBody 770 and consultations at booth #536.

The InBody 770 provides solutions to problems professionals face when treating and preventing diabetes. Problems include:

"Studies have proved InBody devices are an effective tool for managing patients' diabetic risks and symptoms," said Jon Bennett, clinical research manager. "InBody products do not rely on empirical data, therefore, medical professionals can be certain the outputs generated by devices like the InBody 770, accurately reflect changes occurring in the patient."

In less than 60 seconds, an InBody Test provides a comprehensive Result Sheet to help professionals:

InBody devices are space-efficient and medically validated. Information regarding professional demos and other InBody products will also be available at the booth.

About InBody
Founded in 1996, InBody has been changing the health and wellness industry for over 20 years. InBody's award-winning, medically validated devices are used by professionals and consumers in the medical, fitness, research and corporate wellness verticals. Recognized for manufacturing easy, quick and precise body composition analyzers, InBody helps people redefine their health by providing accurate outputs like percent body fat, segmental muscle analysis and, total body water.
For more information, please visit http://www.inbody.com

 

SOURCE InBody USA


These press releases may also interest you

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...



News published on and distributed by: